Asthma trials in Slovakia
9 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.
- Where
- Banská Bystrica, Bratislava, Košice
- Age
- 12 years to 17 years
- People
- 188 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT05776927 - Phase 3Taking peopleA Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
- Where
- Košice, Spišská Nová Ves
- Age
- 12 years to 80 years
- People
- 786 worldwide
- Run by
- Generate Biomedicines
See details and how to joinNCT07359846 - Phase 2Taking peopleA Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
- Where
- Bardejov, Košice, Spišská Nová Ves
- Age
- 18 years to 75 years
- People
- 264 worldwide
- Run by
- Kymera Therapeutics, Inc.
See details and how to joinNCT07323654 - Phase 2Not yet taking people in SlovakiaA Long-term Study of KT-621 Administered Orally to Participants with Asthma Previously Enrolled in a KT-621 Asthma Study
- Where
- Bardejov, Košice, Spišská Nová Ves
- Age
- 18 years and over
- People
- 77 worldwide
- Run by
- Kymera Therapeutics Inc.
See details and how to join2026-526241-98-00 · EU 2026-526241-98-00 - Phase 2Taking peopleA Study of KT-621 Administered Orally to Adult Participants with Moderate to Severe Eosinophilic Asthma
- Where
- Bardejov, Košice, Spišská Nová Ves
- Age
- 18 years and over
- People
- 121 worldwide
- Run by
- Kymera Therapeutics Inc.
See details and how to join2025-523180-38-00 · EU 2025-523180-38-00 - Phase 3Taking peopleA Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents with Severe Uncontrolled Asthma (SOLAIRIA-1)
- Where
- Bardejov, Kosice, Košice, Spišská Nová Ves
- People
- 80 worldwide
- Run by
- Generate Biomedicines Inc.
See details and how to join2025-524040-35-00 · EU 2025-524040-35-00 - Phase 3Taking peopleA double-dummy, double-blind, randomized, active controlled, two-way cross-over study with 12-week treatment duration per period, to evaluate the efficacy and safety of QVM149 (indacaterol acetate / glycopyrronium bromide / mometasone furoate) compared to salmeterol xinafoate/fluticasone propionate in children from 12 years to less than 18 years of age with asthma.
- Where
- Banská Bystrica, Bratislava, Košice, Trnava
- Age
- Up to 17 years
- People
- 68 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2022-502365-26-00 · EU 2022-502365-26-00 - Phase 4Taking peopleBETRI-Prospective: Asthma Control in Single Inhaler ICS/LABA/LAMA (87/5/9 pMDI [BDP/FF/GB - 100/6/12.5 μg]) vs Single Inhaler ICS/LABA (200/6 pMDI [BDP/FF - 200/6 μg])
- Where
- Bardejov, Bratislava, Kosice, Spišská Nová Ves
- Age
- 18 years and over
- People
- 644 worldwide
- Run by
- Chiesi Farmaceutici S.p.A.
See details and how to joinNCT07666490 · EU 2025-524289-56-00 - Phase 2Taking peopleTherapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma
- Where
- Bardejov, Levice, Spišská Nová Ves
- Age
- 18 years to 75 years
- People
- 780 worldwide
- Run by
- Chiesi Farmaceutici S.p.A.
See details and how to joinNCT07301736 · EU 2025-521456-35-00